Sir, from what I have gathered from this board, we will be partnering with big pharma for every diagnostic and therapeutic in our pipeline, so I don't know why ESS would be any different. Johnson & Johnson, Roche, Eli Lily, etc...

Stop being such a skeptic Churbz. Maybe you are over-invested and it is time to sell?

Cheers.